These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11245443)

  • 1. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.
    Kao CH; Tsai SC; Liu TJ; Ho YJ; Wang JJ; Ho ST; ChangLai SP
    Cancer Res; 2001 Feb; 61(4):1412-4. PubMed ID: 11245443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy.
    Liu TJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
    Breast; 2003 Feb; 12(1):58-62. PubMed ID: 14659356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
    Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
    Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Cancer Lett; 2000 May; 153(1-2):95-100. PubMed ID: 10779636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
    Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
    Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
    J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
    Duan XY; Wang JS; Liu M; Guo YM
    Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
    Cui SD; Liu ZZ; Liu H; Li LF; Yang H; Li WL
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):606-8. PubMed ID: 16438870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
    Zhang XM; Zhang ZW; Wu H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
    Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
    Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
    Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
    Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of drug resistance protein related to Tc-99m MIBI breast imaging.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(3B):2021-5. PubMed ID: 10928145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
    Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
    Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
    Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
    Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
    Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.